3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
5
Glioma
4
Multiple Myeloma
3
Carcinoma, Non-Small-Cell Lung
3
Neurofibromatosis 1
2
Neoplasms
2
Lymphoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Astrocytoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Histiocytosis, Langerhans-Cell
1
Ganglioneuroma
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
palbociclib
1
lutetium Lu 177 dotatate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Nivolumab
1
Linear Energy Transfer
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
trametinib
×
30 days
×
Clear all
No trials found.